INTRODUCTION
Studies conducted in both developing and industrialized countries have shown a clear relationship between breast-feeding and a decreased incidence of infections in full-term infants. 1 -8 Specifically, a decreased incidence of gastroenteritis, respiratory infections, otitis media, urinary tract infections, and sepsis has been reported. 1 -8 Dewey et al. conducted a 2-year study comparing infectious morbidity in term infants who had been breast-fed for at least 12 months with infants who had been bottle-fed. They reported that the breast-fed infants had 50% less diarrheal disease and 19% less otitis media during their first year of life. In addition, the average duration of otitis media was longer for bottle-fed infants during both the first and second year of life. The investigators controlled for confounding variables such as number of siblings and day-care attendance. 2 Other investigators have shown a relationship between a decreased incidence of respiratory infections and breast-feeding in term infants. 6, 7 Immune factors such as secretory IgA and lactoferrin are primary mediators in infection prevention. 8 Preterm infants are immunologically immature at birth, and studies of serum concentrations of immunoglobulins have shown that preterm infants may absorb IgA from maternal milk. 9 -11 Past studies examining the effect of human milk on premature infants during their hospitalization have shown that those infants who receive human milk have fewer serious infections in the special care nursery compared to those fed only formula.
9,12 -16 Narayanan et al. 12 conducted a prospective study in 1980 that showed that premature infants who received human milk developed fewer infections than those who received only formula (9 of 32 vs 24 of 38, respectively). In a more recent study, Hylander et al. 15 studied 212 very low birth weight infants and found that the infection (29.3% vs 47.2%) and sepsis/meningitis rates (19.5% vs 32.6%) were lower among the breast-fed than the formula fed infants. Human milk remained independently related to fewer episodes of infection in the special care nursery even after controlling for multiple cofounders. 15 Finally, Schanler et al. 16 reported less episodes of necrotizing enterocolitis and sepsis and decreased length of stay in low birth weight infants who received fortified human milk compared to those who were fed premature infant formula in the special care nursery.
Studies have shown that premature infants are at an increased risk for a variety of infections during their first year of life with rehospitalization a recognized morbidity. 17 -19 Despite research demonstrating the protective effects of human milk for full-term infants during infancy and for premature infants during their hospitalization in the special care nursery, there have been no studies examining the risk of infections during the first year of life in premature infants who have been breast-fed compared to those who
OBJECTIVE:
To determine if ingestion of human milk after discharge reduces symptoms of infections in premature infants.
STUDY DESIGN:
Follow -up of 39 infants with birth weights < 2000 g, 24 of whom received any amount of human milk and 15 of whom received only formula after discharge, was carried out. Mothers were given a calendar on which they recorded any signs of infections and feeding and day -care information. Data were collected at 1 month after discharge and at 3, 7, and 12 months corrected age.
RESULTS:
Results show no differences between groups in birth weight, gestation, gender, maternal age, parental tobacco use, number of siblings, and daycare attendance. Socioeconomic status score was higher in the human milk group. Infants who received human milk had fewer days of upper respiratory symptoms at 1 month after discharge ( p < 0.025 ) and at 7 months corrected age ( p < 0.025 ).
CONCLUSION:
Ingestion of human milk post discharge is associated with a reduction of upper respiratory symptoms in premature infants during their first year of life. Original Article
have received only standard formula after discharge from the special care nursery. The purpose of this study was to prospectively follow premature infants who received any human milk±formula and a control group who received exclusive formula after discharge and compare the incidence of symptoms of infections between the two study groups during their first year of life. We hypothesized that infants who receive any human milk would have less symptoms of infections compared to infants receiving exclusive formula.
METHODS
Between January 1996 and June 1999, 39 infants with birth weights less than 2000 g were sequentially enrolled. Exclusion criteria included infants whose mothers had a positive history of illicit drug use, mental illness, HIV, or were taking medication known to be a contraindication for breast-feeding as well as infants with a positive toxicology screen for illicit drugs or drug withdrawal symptoms at birth. Mothers were approached during their infant's first 2 weeks of life. General information about breast-feeding and bottle-feeding premature infants was given to the mothers. Consent was obtained from the mothers after the nature of the study had been fully explained. Neonatal and demographic data were obtained by chart review and maternal interview. Neonatal and maternal data collected included history of necrotizing enterocolitis, sepsis, grade III to IV intraventricular hemorrhage, periventricular leukomalacia, number of days of orotracheal intubation, number of days of oxygen use, maternal age, maternal and paternal education, occupation, insurance status, and history of smoking. Infants who were less than the 10% in length and weight for their gestational age were considered small for their gestational age. The Hollingshead socioeconomc (SES) status score was calculated using the Hollingshead four-factor scoring system, which is calculated based on maternal and paternal education and occupation. 20 Members of the study staff were available during weekdays to answer questions regarding breast-feeding and bottle-feeding premature infants.
At the time of discharge infants were assigned to one of two study groups based on feeding characteristics. Fifteen infants who were discharged home receiving only formula were placed in the formula group, and 24 infants who were discharged receiving their mother's milk±formula were placed in the human milk group. Infants were discharged home on Neosure formula (22 kcal/oz). Changes in formula after discharge were made by the infants' primary care physician. Typically, once an infant was at least 6 months corrected age and had normal growth parameters, the infant's formula was changed to 20 kcal/oz standard formula.
Mothers of all study infants were given a calendar that included one page per week until 12 months corrected age. Mothers were instructed to record the amount of formula taken, amount of human milk given by bottle, number of breast-feedings, the amount and type of solid foods taken, and day-care information including number of hours of attendance per week and number of children in the day-care group. In addition, any type of symptom or sign of infectious illness such as loose stools (quantity/frequency), rhinorea, coryza, rash, fever, and events including otitis media, bronchiolitis, bronchitis, or pneumonia diagnosed by a physician were recorded.
A home visit was made by a research assistant 1 month after discharge. Anthropometric measurements, including weight, length, and head circumference were obtained and completed calendar information was collected. Weight was obtained using a Detecto infant scale. Length was obtained using a flexible tape measure. Subjects were placed in the supine position with the crown of the head held by either a nurse or a member of the study team. Shoulders and buttocks were flat and the legs were extended at the hips and knees touching the infant's bed with arms flat against the bed. Length was recorded to the nearest 0.1 cm. Head circumference was measured with a flexible tape held superior to the eyebrows to obtain the largest frontal occipital circumference.
Anthropometric measurements and calendar information were obtained at the infant's regularly scheduled 3-and 7-month followup clinic visits. Twelve-month anthropometric measurements and calendar information were collected during a home visit.
Statistical analysis included unpaired t-test for continuous variables and chi-square analysis for discreet variables. Nonparametrics were done for variables with skewed distributions. Analysis of covariance was done covarying for variables that differed significantly between the groups.
RESULTS
Maternal and infant background data are shown in Table 1 . Infants were of similar gestation (29 weeks in both groups) and birth weight (1188±309 vs 1167±219 g in the human milk and formula groups, respectively). There were no differences in neonatal morbidities between the groups. The Hollingshead SES score was higher in the human milk group than in the formula group (42±13 vs 33±14, p=0.05). Scores for the two groups were in the upper middle class and middle class ranges, respectively. There was no difference in insurance status between the groups.
During their hospitalization in the special care nursery infants in the human milk group received a mean of 912±436 ml of human milk and 120±231 ml of formula per week. They were breast-fed a mean of only 14±9 times during their entire stay in the special care nursery. At the time of discharge, five infants were receiving only maternal milk with no formula supplementation; none were fed exclusively at the breast, receiving at least some of their maternal milk feedings by bottle.
Mean postmenstrual age at the time of the 1-month visit was 40±2 weeks (range, 38 to 43 weeks) in the formula group and 41±2 weeks (range, 39 to 47 weeks) in the human milk group ( p=ns). Infants in the human milk group were breast-fed a mean of 6±3 times per day, received a mean of 224±255 ml/day of human milk from bottles (median, 180 ml), and 185±211 ml (median, 115 ml) of formula per day during their first month after discharge from the hospital. Two infants in the human milk group were fed some pureed solid foods before 1 month (this was not a recommendation made by the study staff).
Seven infants no longer received human milk between 1 and 3 months post discharge, whereas 17 infants continued to receive maternal milk during this period. The 17 infants who continued to receive human milk were breast-fed a mean of 4±3 times per day and were bottle-fed a mean of 59±79 ml of human milk per day (median, 21 ml; range, 0 to 10 times per day) and 296±301 ml of formula per day (median, 255 ml; range, 0 to 750 ml) between 1 and 3 months. These infants received a mean of 2.8±6 oz of pureed foods per day (range, 0 to 20 oz, median, 0).
One set of triplets in the human milk group and one infant in the formula group moved before the 7-month visit, and 7-and 12-month data on these infants were therefore not obtained. Nine of the original 24 infants in the human milk group continued breastfeeding between 3 and 7 months corrected age. These infants were breast-fed 4.5±4 times per day (range, 1 to 10 times), received 37.5±106 ml of human milk by bottle (range, 0 to 300 ml; median, 0), and 305.7±373 ml of formula (range, 0 to 840 ml; median, 485 ml) per day. They were fed a mean of 12.4±6 oz (range, 4 to 22 oz) of pureed baby foods per day.
Only five infants continued breast-feeding through 1 year corrected age. These infants were breast-fed a mean of 4.3±1 times per day and received 156.0±223 ml of formula per day (range, 0 to 480 ml; median, 0 ml). None of the five infants who were breast-fed through 1 year of age received maternal milk by bottle. Table 2 shows the feeding style variability in the human milk group. The number of infants in the human milk group who were exclusively formula fed, breast-fed, bottle-fed maternal milk and combinations of these feedings during each time period is shown. Of the 24 infants who received maternal milk after discharge, 21 were followed through 7 and then 12 months corrected age. After discharge, 5 (21%) of the 24 infants were nursed and received maternal milk by bottle but no formula, and 4 (17%) of the 24 were exclusively breast-fed. Fifteen (63%) infants received supplemental formula in addition to maternal milk. The same four infants who were exclusively breast-fed after discharge continued exclusive breast-feeding through 7 months. Only 5 of the 21 (24%) infants *One set of triplets in the human milk group moved before the 7 -month visit, and 7 -and 12 -month data on these infants were therefore not obtained.
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continued to receive human milk between 7 and 12 months corrected age, and 3 of those infants were exclusively breast-fed beginning post discharge through 1 year corrected age. Growth parameters including discharge weight and the infants' 1, 3, 7, and 12 months corrected age weight, length, and head circumferences are shown in Table 3 . Growth parameters were similar between the groups at all time points.
Results of the Mann-Whitney test (nonparametric analysis) showed that infants in the human milk group had fewer days of upper respiratory symptoms (runny nose, cough or both) during their first month after discharge from the special care nursery compared to infants in the formula group: 0.6±1.7, median 0 days vs 3.5±5, median 2 days, Z= À2.86, p=0.016 (Table 4) . From discharge to 3 months corrected age infants in the human milk group had a mean of 6.6±7 days of upper respiratory tract symptoms and infants in the formula group had a mean of 14.6±15 days ( p=0.06). At 7 months corrected age infants in the human milk group had a total of 17.6±15 days of upper respiratory tract symptoms vs 38±26 days in the formula group ( p<0.025). By 1 year corrected age there was no significant difference in total number of days of upper respiratory tract symptoms between the groups (42.7±28 vs 54.8±36 in the human milk and formula groups, respectively).
Post hoc power analysis of the study data for number of days of upper respiratory symptoms revealed a 75% power at 1 month, 65% power at 3 months, 89% power at 7 months, and 30% power at 12 months.
No significant differences in occurrence of less common infections including the number of episodes of otitis media (2.8±3.5 episodes, median 3, range 0 to 15 vs 3.3±6.1, median 0, range 0 to 16 episodes), number of days of bronchiolitis (0.6±2.2, median 0, range 0 to 9 days vs 1.3±2.2, median 0, range 0 to 5 days vs 1.3±2.2, median, 0, range 0 to 5 days) or gastroenteritis (0.3±0.6, median 0, range 0 to 2 days vs 2.7±4.3, median 0, range 0 to 13 days) were found during the first year in the human milk versus formula groups, respectively. In addition, there was no difference in number of visits to primary care physicians (12±5.5, median 10, range 3 to 21 visits vs 14±9.4, median 13.5, range 4 to 33 days in the human milk versus formula groups, respectively). ( ) = range. *One set of triplets in the human milk group and one infant in the formula group moved before the 7 -month visit, and 7 -and 12 -month data on these infants were therefore not obtained. 
DISCUSSION
Our data support our hypothesis and add to the previous literature supporting the protective effects of human milk against infections. 1 -8,12 -16 The anti-infective properties of preterm human milk have been established for premature infants in the special care nursery 12 -16 but anti-infective effects during the first year of life have not been previously studied. Although infants were enrolled with birth weights <2000 g, only two infants in this study had birth weight >1500 g. In addition, 11 infants had birth weight <1000 g, and were therefore at highest risk for adverse sequelae. 17 -19 The milk produced by a woman who delivers prematurely differs from that produced after a full-term pregnancy, 21 -27 and the transition from colostrum to mature milk proceeds much slower after premature delivery compared to a term delivery. 22, 23 During the first month after parturition, preterm milk maintains a nutritional composition similar to that of colostrum, which contains higher concentrations of protein, sodium, and chloride and lower amounts of potassium, carbohydrate, fat, and some vitamins. 22, 23 Milk from preterm mothers has a greater concentration of immunoglobulin A, lysosyme and lactoferrin and a different leukocyte pattern compared to milk from term mothers. 21 -27 Ronayne de Ferrer et al. 21 measured IgA levels in samples from preterm and term human milk during the first month postpartum. The concentration of IgA tended to be constant in the preterm group whereas it showed a decreasing trend in the term group. From day 10 onward, IgA levels in preterm milk were significantly higher than in term milk. Goldman et al. 22 examined the immunologic components of premature and term human milk during the second through twelfth week after delivery. Consistent with Ronayne de Ferrer, secretory IgA was found to be the predominant form of IgA in preterm milk. Furthermore, total and secretory IgA levels in preterm milk rose linearly during the sixth through twelfth week whereas the concentrations of IgA did not change in term milk during that period. These findings support the idea that premature infants, whose immune system is poorly developed after birth, may benefit from more stable levels of IgA when fed their own mother's milk. Finally, Goldman et al. 22 and Goldman and Goldblum 23 reported that leukocyte counts in preterm milk were usually lower at 2 weeks and higher at 12 weeks than in term milk.
Our data support anti-infective properties of preterm human milk that extend to 7 months corrected age. In fact, only five infants remained on breast milk at 12 months of age limiting our ability to assess the impact of human milk on infection at 7 to 12 months of age. The mechanism of this effect may be similar to that of term milk, which has been shown to protect full-term infants throughout infancy. Although we attempted to control for potential confounding variables such as socioeconomic status, parental smoking, and day-care attendance, there may be, however, other factors influencing upper respiratory symptoms during infancy in this population. It is notable that infants of nonsmoking parents had less total number of days of upper respiratory symptoms during their first year (54±33 vs 27±11, p<0.05). Replication of this study with a larger cohort is needed.
The small number of infants in this study makes analysis of less common, more serious infections inconclusive. A trend appears to exist for otitis media, bronchiolitis, and gastroenteritis, but again, a larger cohort is needed to examine the potential effect of human milk in prevention of these illnesses.
Both study groups had similar growth parameters through 12 months corrected age. Any difference in growth patterns between premature infant formula and human milk would, however, be minimized by the supplemental formula or human milk fortifier given to the human milk-fed infants.
Our study was unique in that it documents ingestion of human milk after discharge from the special care nursery. Our results showed a steady decrease in the percent of infants receiving human milk after discharge dropping to 24% followed through 12 months. The mothers most likely to continue providing human milk were those providing exclusive breast-feedings 1 month after discharge.
We conclude that human milk reduces upper respiratory symptoms in low birth weight infants through 7 months corrected age. The provision of human milk and breast-feeding should be enthusiastically supported both in the special care nursery and after discharge.
